Formula for citrate volume adjustment In high hematocrit

When collecting blood into a citrate bulb (commonly used for coagulation tests like PT, APTT, etc.), the standard anticoagulant-to-blood ratio is 1 part citrate to 9 parts blood. However, if the patient has a significantly elevated hematocrit (usually above 55%), this ratio needs to be adjusted because the plasma volume (the actual liquid portion of blood) is reduced in these cases. If you don’t correct for this, the excess citrate can interfere with clotting test results.

Formula for citrate volume adjustment:

C=(1.85×10−3)×(100−HCT)×VC = (1.85 \times 10^{-3}) \times (100 – HCT) \times VC=(1.85×10−3)×(100−HCT)×V

Where:

  • C = volume of citrate to be used (mL)
  • HCT = patient hematocrit (%)
  • V = volume of whole blood sample required (mL)

DOWNLOAD EXCEL SHEET WITH FORMULA HERE-

Explanation:

  • High hematocrit means less plasma, so the citrate anticoagulant is too concentrated.
  • The formula reduces the citrate volume accordingly.

Example Calculation:

  • Target blood volume (V) = 5 mL
  • Patient hematocrit = 65%

C=(1.85×10−3)×(100−65)×5=0.323875 mL citrateC = (1.85 \times 10^{-3}) \times (100 – 65) \times 5 = 0.323875 \text{ mL citrate}C=(1.85×10−3)×(100−65)×5=0.323875 mL citrate

This is less than the usual 0.5 mL citrate for a 5 mL tube (since the default assumes normal hematocrit).

In practice:

  • Labs may use pre-filled citrate tubes that aren’t adjustable. In these cases, you might need to either:
    • Draw a smaller volume of blood.
    • Use specialized low-volume citrate tubes for high HCT patients.
  • Most analyzers also allow you to input a corrected citrate ratio if needed.

Quick Reference Chart (for common volumes)

HCT (%)Required Blood Volume (mL)Corrected Citrate Volume (mL)
45
5ml0.5 mL (Standard tube)
555ml0.416 mL
605ml0.370 mL
655ml0.324 mL
705ml0.277 mL
755ml0.231 mL


References:
Clinical and Laboratory Standards Institute (CLSI) – H21-A5:
Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline – Fifth Edition.
CLSI document H21-A5 (2018).

Adcock-Funk DM, et al. (2012).
“To Adjust or Not to Adjust: The Impact of High Hematocrit on Coagulation Testing.”
Lab Medicine, 43(6):231-235.
DOI: 10.1309/LM2YWON63RGUUDXX
This article reviews why high HCT interferes with coagulation assays and how to apply the correction formula.
Garcia, R.C., & Spinner, D.S. (2001).
“Impact of Hematocrit on Coagulation Testing.”
Clinical Laboratory Science, 14(4): 231-235.
Discusses real-world implications of failing to adjust citrate volume in high HCT patients, particularly in neonates and polycythemia cases.
Rodak BF, Fritsma GA, Doig K. (2020).
Hematology: Clinical Principles and Applications.
Elsevier – 5th Edition, Chapter on Preanalytical Variables in Coagulation Testing.
Covers anticoagulant adjustments for hematocrit outside the normal range.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.